“…Some high-performance thin-layer chromatography (HPTLC) methods are reported for the assay of NOACs and ROS either alone or in combination with other drugs in bulk & pharmaceutical formulations [, , , , , , , 7,8,9,10,11,12,13,14]. RIV is assayed using HPTLC in human plasma [15] and also HPTLC is used to quantify ROS in rabbit plasma [16]. Most bioanalytical techniques available in the literature to quantify NOACs are based on liquid chromatography in human plasma; using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) [, 17, 18], high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) [, , 19,20,21], high-performance liquid chromatography-mass spectrometry (HPLC-MS) [22] and high-performance liquid chromatography-diode array detector (HPLC-DAD) [23].…”